Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
&NA;
1995.
Clozapine.
Reactions Weekly,
Vol. &NA;,
Issue. 569,
p.
6.
Szabadi, E.
1996.
Clozapine-induced hypersalivation and the alpha-2 adrenoceptor.
British Journal of Psychiatry,
Vol. 169,
Issue. 3,
p.
380.
Carvajal, Alfonso
and
Martín Arias, Luis H.
1997.
Vol. 20,
Issue. ,
p.
36.
Szabadi, E.
1997.
Clozapine-induced hypersalivation.
British Journal of Psychiatry,
Vol. 171,
Issue. 1,
p.
89.
Blake, Tracey-Jane
Tillery, Claire E.
and
Reynolds, Gavin P.
1998.
Antipsychotic drug affinities at α2-adrenoceptor subtypes in post-mortem human brain.
Journal of Psychopharmacology,
Vol. 12,
Issue. 2,
p.
151.
Reynolds, GP
1998.
Receptor mechanisms of antipsychotic drug atypicality.
European Psychiatry,
Vol. 13,
Issue. S1,
p.
5s.
Reynolds, GP
1998.
Receptor mechanisms of antipsychotic drug atypicality.
European Psychiatry,
Vol. 13,
Issue. ,
p.
5s.
Ceravolo, Roberto
Salvetti, Stefania
Piccini, Paola
Lucetti, Claudio
Gambaccini, Gianna
and
Bonuccelli, Ubaldo
1999.
Acute and chronic effects of clozapine in essential tremor.
Movement Disorders,
Vol. 14,
Issue. 3,
p.
468.
Davydov, Liya
and
Botts, Sheila R
2000.
Clozapine-Induced Hypersalivation.
Annals of Pharmacotherapy,
Vol. 34,
Issue. 5,
p.
662.
Bai, Ya-Mei
Lin, Chao-Cheng
Chen, Jen-Yeu
and
Liu, Win-Chien
2001.
Therapeutic Effect of Pirenzepine for Clozapine-Induced Hypersalivation: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study.
Journal of Clinical Psychopharmacology,
Vol. 21,
Issue. 6,
p.
608.
Cree, Adrian
Mir, Shameem
and
Fahy, Thomas
2001.
A review of the treatment options for clozapine-induced hypersalivation.
Psychiatric Bulletin,
Vol. 25,
Issue. 3,
p.
114.
Tsai, Shih-Jen
Wang, Ying-Chieh
Yu, W.-Y.
Lin, Ching-Hua
Yang, Kuan-Hung
and
Hong, Chen-Jee
2001.
Association analysis of polymorphism in the promoter region of the α2a-adrenoceptor gene with schizophrenia and clozapine response.
Schizophrenia Research,
Vol. 49,
Issue. 1-2,
p.
53.
Basu, Amlan
Tsapakis, Eva
and
Aitchison, Kathy
2004.
Pharmacogenetics and Psychiatry.
Current Psychiatry Reports,
Vol. 6,
Issue. 2,
p.
134.
Kirchheiner, J
Nickchen, K
Bauer, M
Wong, M-L
Licinio, J
Roots, I
and
Brockmöller, J
2004.
Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response.
Molecular Psychiatry,
Vol. 9,
Issue. 5,
p.
442.
2005.
The Maudsley 2005-2006 Prescribing Guidelines.
p.
7.
Praharaj, Samir Kumar
Verma, Pankaj
Roy, Dipayan
and
Singh, Anuradha
2005.
Is clonidine useful for treatment of clozapine-induced sialorrhea?.
Journal of Psychopharmacology,
Vol. 19,
Issue. 4,
p.
426.
Fitzsimons, Joanna
Berk, Michael
Lambert, Timothy
Bourin, Michel
and
Dodd, Seetal
2005.
A review of clozapine safety.
Expert Opinion on Drug Safety,
Vol. 4,
Issue. 4,
p.
731.
Kahl, K. G.
Trillenberg, P.
Kordon, A.
Lencer, R.
Klein, C.
and
Hagenah, J.
2005.
Therapie der Clozapin-induzierten Hypersalivation mit Botulinum-Toxin B.
Der Nervenarzt,
Vol. 76,
Issue. 2,
p.
205.
Praharaj, Samir Kumar
Arora, Manu
and
Gandotra, Sachin
2006.
Clozapine-induced sialorrhea: pathophysiology and management strategies.
Psychopharmacology,
Vol. 185,
Issue. 3,
p.
265.
Duggan, L
Cahill, C
Udu, V
and
Duggan, Lorna
2006.
Cochrane Database of Systematic Reviews.
eLetters
No eLetters have been published for this article.